Showing results (181-190 of 253) with videos related to

Sort By:
Pageof 26
Cancer Immunology Research|May 20, 2016
Preserved Activity of CD20-Specific Chimeric Antigen Receptor-Expressing T Cells in the Presence of RituximabGregory A Rufener, Oliver W Press, Philip Olsen, et al.
Blood|February 27, 2008
DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cellsKellie V Rosinski, Nobuharu Fujii, Jeffrey K Mito, et al.
Leukemia & Lymphoma|July 11, 2022
Predictors of cytopenias after treatment with axicabtagene ciloleucel in patients with large B-cell lymphomaLorena Panaite, Qian Vicky Wu, Jenna Voutsinas, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 7, 2023
Anti-HLA antibodies in recipients of CD19 versus BCMA-targeted CAR T-cell therapyJoshua A Hill, Erika S Kiem, Atif Bhatti, et al.
Research Square|May 15, 2024
Sensitive bispecific chimeric T cell receptors for cancer therapySylvain Simon, Grace Bugos, Rachel Prins, et al.
Cancer Immunology Research|June 8, 2019
Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical TrialShihong Zhang, Karan Kohli, R Graeme Black, et al.
Science Translational Medicine|July 5, 2013
TCR-ligand koff rate correlates with the protective capacity of antigen-specific CD8+ T cells for adoptive transferMagdalena Nauerth, Bianca Weißbrich, Robert Knall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patientsScott S Tykodi, Nobuharu Fujii, Nathalie Vigneron, et al.
Pageof 26